Pages that link to "Item:Q1055358"

The following pages link to A model for the resistance of tumor cells to cancer chemotherapeutic agents (Q1055358):

Displaying 47 items.

• Optimal control of a mathematical model for cancer chemotherapy under tumor heterogeneity (Q326554) (← links)
• Extinction models for cancer stem cell therapy (Q427095) (← links)
• A survey of optimization models on cancer chemotherapy treatment planning (Q478056) (← links)
• A mixed model of carcinogenesis with applications to retinoblastoma (Q584091) (← links)
• The worst drug rule revisited: mathematical modeling of cyclic cancer treatments (Q644401) (← links)
• Optimizing multi-modal cancer treatment under 3D spatio-temporal tumor growth (Q669146) (← links)
• Numerical simulation of a stochastic model for cancerous cells submitted to chemotherapy (Q751535) (← links)
• Role of optimal control theory in cancer chemotherapy (Q915680) (← links)
• Stochastic modeling of cellular colonies with quiescence: an application to drug resistance in cancer (Q935970) (← links)
• The effect of cellular differentiation on the development of permanent drug resistance (Q1064978) (← links)
• The transient solution of the linear birth-death process with random spontaneous mutation (Q1082281) (← links)
• Optimal control of tumor size used to maximize survival time when cells are resistant to chemotherapy (Q1196632) (← links)
• Low-intensity combination chemotherapy maximizes host survival time for tumors containing drug-resistant cells (Q1196633) (← links)
• A mathematical model of the P-glycoprotein pump as a mediator of multidrug resistance (Q1199386) (← links)
• Cancer chemotherapy with immunostimulation: A nonhomogeneous stochastic model for drug resistance. I: One drug case (Q1262234) (← links)
• A mathematical model for the inhibition of the multidrug resistance- associated \(p\)-glycoprotein pump (Q1319883) (← links)
• Optimal drug regimens in cancer chemotherapy for single drugs that block progression through the cell cycle (Q1340483) (← links)
• Chemotherapeutic treatments: A study of the interplay among drug resistance, toxicity and recuperation from side effects (Q1361432) (← links)
• Conflicting objectives in chemotherapy with drug resistance (Q1364689) (← links)
• The effect of heterogeneity on optimal regimens in cancer chemotherapy (Q1408746) (← links)
• Individual-based approaches to birth and death in avascular tumors (Q1433139) (← links)
• Modelling growth of drug resistant cancer populations as a system with positive feedback (Q1433149) (← links)
• Optimal control for a stochastic model of cancer chemotherapy (Q1595411) (← links)
• Optimal therapy scheduling based on a pair of collaterally sensitive drugs (Q1670458) (← links)
• Modeling the dynamics of heterogeneity of solid tumors in response to chemotherapy (Q1696402) (← links)
• Modeling the chemotherapy-induced selection of drug-resistant traits during tumor growth (Q1752344) (← links)
• On the probability of random genetic mutations for various types of tumor growth (Q1758071) (← links)
• Multistage carcinogenesis and the fraction at risk (Q1764629) (← links)
• Maximum tolerated dose versus metronomic scheduling in the treatment of metastatic cancers (Q1790751) (← links)
• Drug kinetics and drug resistance in optimal chemotherapy (Q1804871) (← links)
• Chemotherapeutic treatments involving drug resistance and level of normal cells as a criterion of toxicity (Q1804872) (← links)
• A stochastic model for the origin and treatment of tumors containing drug-resistant cells (Q1820076) (← links)
• Optimal control of cancer chemotherapy with delays and state constraints (Q2159444) (← links)
• Stochastic modeling of drug resistance in cancer (Q2195074) (← links)
• The impact of cell density and mutations in a model of multidrug resistance in solid tumors (Q2254660) (← links)
• Distributed parameters deterministic model for treatment of brain tumors using Galerkin finite element method (Q2270537) (← links)
• Modeling continuous levels of resistance to multidrug therapy in cancer (Q2307049) (← links)
• On the role of tumor heterogeneity for optimal cancer chemotherapy (Q2328346) (← links)
• A 3-compartment model for chemotherapy of heterogeneous tumor populations (Q2340517) (← links)
• Modeling the effects of space structure and combination therapies on phenotypic heterogeneity and drug resistance in solid tumors (Q2352430) (← links)
• Optimal policies of non-cross-resistant chemotherapy on Goldie and Coldman's cancer model (Q2437023) (← links)
• The fixed-size Luria-Delbrück model with a nonzero death rate (Q2472891) (← links)
• An alternative approach to modelling relapse in cancer with an application to adenocarcinoma of the prostate (Q2488639) (← links)
• Optimal control problems for differential equations applied to tumor growth: state of the art (Q2690605) (← links)
• Опухолевый рост и возможности математического моделирования системных процессов (Q5230453) (← links)
• A cellular automata model of chemotherapy effects on tumour growth: targeting cancer and immune cells (Q5861112) (← links)
• Impact of resistance on therapeutic design: a Moran model of cancer growth (Q6124362) (← links)